“Efficacy and Safety of Secukinumab in Treatment of Moderate to Severe Psoriasis”, J Pak Assoc Dermatol, vol. 32, no. 1, pp. 9–14, Mar. 2022, doi: 10.66344/jpad.32.1.2022.1785.